In 2022, research moved full steam ahead with the creation of the FA Cancer Consortium as well as 2 new projects and ongoing programs.
Six grants wrapped up, as five more are funded. See the impact inside.
The FA Cancer Consortium aims to streamline cancer care decision-making processes for patients with FA through evidence-based research.
In early 2022, four new grants were awarded to advance research in FA cancer preclinical models, Fanconi Anemia Neurological Syndrome (FANS), and mental health.
Team will research new approaches to treating cancers related to HPV and Fanconi anemia
In summer 2021, FA researchers and clinicians met virtually to share updates on specific topics including gene therapy, bone marrow failure, DNA repair, and cancer.